key: cord-0810695-7ac714v4
authors: Berry, L.; Jones, K.; Robbins, T.; Anderson, N.; Morgan, N.; Patel, K.; Hardy, Andrew; Kyrou, I.; Randeva, H.
title: Audit of vaccination status of health-care workers who tested positive for SARS-CoV-2
date: 2021-09-02
journal: Journal of Clinical Virology Plus
DOI: 10.1016/j.jcvp.2021.100040
sha: a96d0a4e24dfbb45f34637dd7c7a2db3cc7f84cc
doc_id: 810695
cord_uid: 7ac714v4

Multiple SARS-CoV-2 vaccinations have shown excellent efficacy during clinical trials. However, post vaccine surveillance is important to confirm ‘real-world’ findings of vaccine efficacy and safety. It is therefore imperative to identify individuals that become infected with SARS-CoV-2 post vaccination. We investigated the vaccination status of staff that had tested positive in a cohort of healthcare workers in one large tertiary hospital in the UK. At the time of the investigation, 8th December 2020 to 13th March 2021, 11,871 staff had been vaccinated and 225 staff tested positive for SARS-CoV-2. This period coincided with the second wave of SARS-CoV-2 infections in the UK which was driven by the Alpha variant. No healthcare workers who were double vaccinated had a positive PCR test for SARS-CoV-2 during this study period confirming vaccination with Pfizer BioNTec BNT162b2 gives excellent protection against infection of this variant.

On the 8th December 2020 the world's first dose of COVID-19 vaccine, was given to a recipient 26 outside of clinical trials. This dose of Pfizer BioNTec BNT162b2 was administered at University 27 Hospital Coventry and Warwickshire NHS Trust (UHCW), a large tertiary hospital located in the West 28 Midlands, England. Healthcare workers who receive their vaccine on the hospital site are only 29 offered the Pfizer BioNTec BNT162b2. In rare circumstances where the Pfizer vaccination was 30 contraindicated due to history of severe allergy, staff may have been vaccinated elsewhere with the 31 AstraZeneca (ChAdOx1). At the time of this study these were the only two vaccines available in the 32 UK. Clinical trial data for the Pfizer vaccination recommended an interval of 21 days between first 33 and second doses of vaccine and vaccine induced protection is considered to be achieved 14 days 34 after the first vaccine dose. On the 30 th December 2020 the Joint Committee on Vaccination and 35 Immunisation (JCVI) decided to amend the vaccine schedule extent the interval between doses to 36 12 weeks, allowing more people to receive at least one dose of vaccine to maximise the short term 37 impact at a time when cases of SARS-CoV-2 in the UK were high [1]. The subsequent speed at which 38 the vaccination programme in the UK has been rolled has been phenomenal. 108 109 The majority of staff members were white British (76%). The most common reason for having a PCR 110 test was due to ward outbreak surveillance screening (8) , followed by symptomatic screens (5) ☒ The authors declare that they have no known competing financial interests or personal 190 relationships that could have appeared to influence the work reported in this paper. 191 192 ☐The authors declare the following financial interests/personal relationships which may be 193 considered as potential competing interests: 194 195 196 197 

Letter to the profession from the UK Chief Medical Officers regarding the UK 201 COVID-19 vaccination programmes

COVID-19 in the UK). Vaccinations report

COVID-19: Protecting Healthcare Workers is 209 a priority

JCVI. Independent report: Joint Committee on Vaccination and Immunisation: Advice 211 on priority groups for COVID-19 vaccination

COVID-19 vaccine coverage in health-care workers in England and 217 effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, 218 multicentre, cohort study. The Lancet

Initial report of decreased SARS-CoV-2 viral load after 220 inoculation with the BNT162b2 vaccine

Chapter 14a COVID-19 -SARS-CoV-2, in The Green Book2021, Public Health England

Vaccine side-effects and SARS-CoV-2 infection after vaccination in

SOB: shortness of breath *Cycle threshold (CT) values do not register the first 10 rounds of amplification. Results obtained from the Abbott M2000 have been adjusted to reflect this (10 CT's added). Standard curves were not used to generate CT values.